title: Aging is associated with an impaired coronary microvascular response to vascular endothelial growth factor in patients.
abstract: OBJECTIVE
  If growth factor and cell-based therapy are to become therapeutic strategies, a better understanding of their physiologic effects in various patient populations will need to be gained. In this study, we examined age-dependent differences in vascular endothelial growth factor signaling before and after cardioplegia/cardiopulmonary bypass.
  
  
  METHODS
  Atrial tissue and peripheral blood of patients undergoing surgery were examined before and after cardioplegia/cardiopulmonary bypass. Patients were divided into younger (age < 70) and older (age > or = 70) groups. Coronary microvascular responses, expression of vascular endothelial growth factor and its downstream signaling molecules, and the number of CD34+ progenitor cells before and after cardioplegia/cardiopulmonary bypass were compared between groups.
  
  
  RESULTS
  Advanced age was associated with impaired basal coronary microvascular response to vascular endothelial growth factor (-13% +/- 5% at 10(-10) mol/L vascular endothelial growth factor; P = .04), whereas basal relaxation response to substance P and sodium nitroprusside were similar between groups. After cardioplegia/cardiopulmonary bypass, the microvascular response to vascular endothelial growth factor significantly worsened in both groups (both P < or = .05), and response to substance P (P = .05) was significantly impaired only in older patients. Vascular endothelial growth factor expression increased after cardioplegia/cardiopulmonary bypass in older (P = .01 vs before cardioplegia/cardiopulmonary bypass), but not younger (P = .20) patients. Expression of other signaling molecules was unaffected by age or surgery. Circulating CD34+ cells increased after cardioplegia/cardiopulmonary bypass in all patients but to a greater extent in younger patients (P = .01).
  
  
  CONCLUSIONS
  The coronary microvascular response to vascular endothelial growth factor is impaired in older patients. Combined with reduced progenitor cell mobilization, these results suggest new mechanisms for reduced angiogenic response in older patients.
authors.affiliation: Division of Cardiothoracic Surgery, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, Mass 02215, USA.
authors.forename: Shigetoshi
authors.initials: S
authors.lastname: Mieno
authors.forename: Munir
authors.initials: M
authors.lastname: Boodhwani
authors.forename: Richard T
authors.initials: RT
authors.lastname: Clements
authors.forename: Basel
authors.initials: B
authors.lastname: Ramlawi
authors.forename: Neel R
authors.initials: NR
authors.lastname: Sodha
authors.forename: Jian
authors.initials: J
authors.lastname: Li
authors.forename: Frank W
authors.initials: FW
authors.lastname: Sellke
mesh_terms: D000368:Aged; D000375:Aging; D018952:Antigens, CD34 / Q000096:biosynthesis; D002315:Cardiopulmonary Bypass; D003331:Coronary Vessels / Q000503:physiopathology*; D005260:Female; D006324:Heart Arrest, Induced; D006801:Humans; D008297:Male; D008833:Microcirculation; D008875:Middle Aged; D013234:Stem Cells / Q000502:physiology; D042461:Vascular Endothelial Growth Factor A / Q000502:physiology*
chemical_list: D018952:Antigens, CD34; D042461:Vascular Endothelial Growth Factor A